Insomnia: Causes, Types, and Evidence-Based Treatments (2026)

Insomnia is the most common sleep disorder, affecting approximately 30% of adults with occasional symptoms and 10% with chronic, clinically significant insomnia. Despite this prevalence, it remains undertreated — many people either suffer in silence, use alcohol as an unofficial sleep aid, or receive prescription sleeping medications without being offered the evidence-based behavioral treatments that produce superior long-term outcomes. This guide covers what insomnia actually is, what causes it, and the treatments that research consistently shows work best.

What Insomnia Actually Is

Insomnia is defined by difficulty initiating sleep, maintaining sleep, or waking too early — occurring at least 3 nights weekly for at least 3 months (for chronic insomnia), causing significant distress or daytime impairment, despite adequate opportunity for sleep. This last criterion is important: someone choosing to sleep fewer hours is not insomniac; someone who has adequate time and opportunity for sleep but cannot achieve or maintain it is.

Insomnia is sometimes categorized as:

Sleep-onset insomnia: Difficulty falling asleep at the beginning of the night
Sleep-maintenance insomnia: Waking during the night and difficulty returning to sleep
Early-morning waking insomnia: Waking significantly before the desired/needed time and unable to return to sleep

Many people experience combinations of these patterns, and the pattern may shift over time.

The Causes: What Maintains Insomnia

The most clinically useful model for understanding chronic insomnia is the "3P model" — Predisposing, Precipitating, and Perpetuating factors:

Predisposing Factors

Individual vulnerabilities that increase insomnia risk: genetic predisposition to hyperarousal, tendency toward anxiety and rumination, female sex (women have significantly higher insomnia rates than men), older age, and certain temperamental features (high neuroticism, perfectionism).

Precipitating Factors

Events or circumstances that trigger an initial episode: stressful life events, medical illness, shift in schedule, medication changes, grief, or life transitions. Most people experience brief acute insomnia in response to such triggers — for most, it resolves when the trigger resolves.

Perpetuating Factors

This is the key insight of the 3P model: chronic insomnia is often maintained not by the original precipitating cause but by behavioral and cognitive responses to initial sleep difficulty that, ironically, worsen and perpetuate the problem. The most important perpetuating factors:

Spending excess time in bed: To compensate for poor sleep, people often go to bed earlier and stay later — but spending more time in bed fragmented sleep further and conditions the mind to associate bed with wakefulness and frustration
Conditioned arousal: After nights of lying awake in bed, the bedroom and bedtime become conditioned triggers for alertness and anxiety rather than sleep
Hyperarousal and sleep-monitoring: Watching the clock, monitoring sleep quality, worrying about consequences of poor sleep, and treating sleep as a performance — all increasing arousal at precisely the time that reduced arousal is needed
Safety behaviors: Napping to compensate, caffeine to manage daytime fatigue, irregular schedules, avoiding social commitments due to sleep concerns — all of which reduce the homeostatic sleep pressure and circadian regularity that support good sleep

Cognitive Behavioral Therapy for Insomnia (CBT-I): The Gold Standard

CBT-I is the treatment recommended as first-line by the American College of Physicians, the American Academy of Sleep Medicine, and the NIH — ahead of pharmacological treatments. Multiple systematic reviews and meta-analyses confirm that CBT-I produces superior long-term outcomes compared to sleeping medications, with benefits that are maintained or even improve after treatment ends (unlike medication effects which often cease with discontinuation).

CBT-I consists of several components:

Stimulus Control

Rebuilding the association between the bed/bedroom and sleepiness rather than wakefulness. Core instructions: use the bed only for sleep and sex; if unable to sleep after approximately 20 minutes, get up and do a quiet, non-stimulating activity in another room until sleepy, then return to bed. This approach directly counters conditioned arousal by breaking the bed-wakefulness association through consistent behavior change.

Sleep Restriction Therapy

Counterintuitively, one of CBT-I's most powerful tools involves initially restricting time in bed to match current actual sleep time (not desired sleep time). If someone spends 9 hours in bed but only sleeps 5 hours, restricting bed time to 5-5.5 hours dramatically increases sleep pressure and improves sleep efficiency (ratio of time asleep to time in bed). As sleep efficiency improves, time in bed is gradually extended. This initially produces short-term sleepiness but creates the most efficient, consolidated sleep achievable, then rebuilds duration from this solid foundation.

Cognitive Restructuring

Identifying and challenging unhelpful beliefs about sleep that maintain insomnia: catastrophizing about consequences of poor sleep ("I'll never function tomorrow"), unrealistic expectations ("I must get 8 hours or I'll be useless"), and misattribution of daytime problems ("everything bad today is because of my sleep"). These cognitive patterns increase nocturnal arousal and create performance anxiety around sleep, making the very thing you're worried about more likely to occur.

Sleep Hygiene Education

While sleep hygiene alone is insufficient for treating clinical insomnia, addressing significant hygiene factors — consistent sleep/wake schedule, bedroom environment optimization, caffeine and alcohol management, pre-sleep routine — provides a supportive foundation for the behavioral components above.

Relaxation Techniques

Progressive muscle relaxation, diaphragmatic breathing, and mindfulness practices reduce the physiological arousal component of insomnia, lowering the physical activation that keeps the hyperaroused insomniac awake.

Pharmacological Treatments: What's Available and Its Limitations

Sleeping medications produce faster initial effects than CBT-I but show inferior long-term outcomes and significant side effects:

Benzodiazepines (temazepam, triazolam): Effective short-term but with significant tolerance, dependence, and withdrawal risks; rebound insomnia common on discontinuation; cognitive impairment with regular use
Z-drugs (zolpidem/Ambien, eszopiclone/Lunesta, zaleplon): Similar mechanism to benzodiazepines with similar limitations; associated with sleep-related behaviors (sleepwalking, sleep eating)
Dual orexin receptor antagonists (suvorexant/Belsomra, lemborexant/Dayvigo): Newer class with different mechanism; generally better side effect profile for longer-term use than benzodiazepines or Z-drugs
Low-dose doxepin: FDA-approved specifically for sleep maintenance insomnia; works via histamine antagonism
Melatonin: Most effective for sleep timing issues (delayed sleep phase, jet lag) rather than classic insomnia; over-the-counter; generally safe

The American College of Physicians explicitly recommends CBT-I as first-line treatment before pharmacological approaches, recognizing that medication addresses symptoms without treating the underlying behavioral and cognitive perpetuating factors that maintain chronic insomnia.

Frequently Asked Questions

Q: How do I find a CBT-I therapist?

CBT-I trained therapists can be found through the Society of Behavioral Sleep Medicine's provider directory (behavioralsleep.org), through psychology practice directories filtering for sleep specialization, and through sleep centers at academic medical centers. For those without easy access to in-person CBT-I, digital CBT-I programs have demonstrated comparable effectiveness to in-person delivery in multiple clinical trials — validated programs include Sleepio, Somryst (FDA-authorized), and several research-backed apps. Your primary care physician can also refer to sleep specialists, though ensuring the referral specifies CBT-I (rather than simply medication management) is often necessary.

Q: If I have insomnia, should I sleep in if I had a bad night?

From a CBT-I perspective, no — and this is one of the most counterintuitive but important aspects of the behavioral treatment. Sleeping in after a poor night reduces the next night's sleep pressure, makes the following night harder, and creates inconsistent sleep timing that further disrupts circadian rhythm. Maintaining a consistent wake time regardless of previous night's sleep quality is one of the most important behavioral prescriptions in CBT-I — it preserves the sleep pressure that makes the following night's sleep easier. While this feels harsh on the morning after a bad night, it's the approach that produces the fastest improvement in insomnia over weeks.

Q: Is insomnia the same as anxiety?

They frequently co-occur and share mechanisms, but they're distinct conditions. Anxiety can certainly precipitate and perpetuate insomnia — nocturnal rumination, hyperarousal, and worry about sleep or life circumstances are common features of both. However, insomnia can exist without a diagnosable anxiety disorder (many people with insomnia don't have generalized anxiety by clinical criteria), and anxiety disorders can exist without insomnia as a primary feature. The treatment implications matter: CBT-I specifically targets the sleep-maintaining factors and is often sufficient for insomnia even when anxiety is part of the picture; when anxiety is severe and primary, treating the anxiety disorder directly (often with CBT for anxiety) may be necessary alongside or before CBT-I.

Q: Can diet affect insomnia?

Some dietary factors have documented effects on sleep quality: heavy meals close to bedtime can disrupt sleep through digestive discomfort and increased metabolism; high-sugar foods may cause blood sugar fluctuations that interrupt sleep; alcohol initially sedates but disrupts sleep architecture, particularly suppressing REM sleep and causing fragmentation in the second half of the night; caffeine's 5-7 hour half-life means afternoon consumption meaningfully affects sleep onset; and research suggests higher dietary fiber, Mediterranean-pattern eating, and adequate magnesium intake are associated with better sleep quality. While dietary optimization isn't a primary treatment for clinical insomnia, addressing significant dietary factors that disrupt sleep is part of the comprehensive sleep hygiene picture.

Q: How long does CBT-I take to work?

Most CBT-I programs are delivered over 4-8 sessions (weekly or biweekly), and many people see meaningful improvement within 2-4 weeks of implementing the behavioral components — particularly sleep restriction and stimulus control, which often produce faster subjective improvement than expected given their initially counterintuitive nature. The cognitive components and full consolidation of gains typically take the full 6-8 weeks. Importantly, sleep often temporarily worsens in the first 1-2 weeks of sleep restriction before improving dramatically — this expected initial worsening leads some people to prematurely abandon the treatment. Understanding that initial temporary worsening is part of the mechanism (building sleep pressure) rather than a sign of failure is important for completing the full course.

References:
1. Qaseem A et al. "Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians." Annals of Internal Medicine. 2016. acpjournals.org
2. Morin CM et al. "Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia." JAMA. 2009.
3. Trauer JM et al. "Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis." Annals of Internal Medicine. 2015.
4. Spielman AJ et al. "A behavioral perspective on insomnia treatment." Psychiatric Clinics of North America. 1987.